As of November 2024, SymBio Pharmaceuticals has a market cap of $71.26M. This makes SymBio Pharmaceuticals the world's 23440th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $53.73M | -24.29% |
2023 | $70.97M | -61.59% |
2022 | $184.75M | -43.84% |
2021 | $328.99M | 202.11% |
2020 | $108.90M | -37.56% |
2019 | $174.41M | -20.13% |
2018 | $218.37M | -13.24% |
2017 | $251.70M | -10.25% |
2016 | $280.43M | 5.17% |
2015 | $266.64M | -35.01% |
2014 | $410.30M | -6.05% |
2013 | $436.73M | 26.67% |
2012 | $344.79M | -37.24% |
2011 | $549.37M | - |